These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2349910)

  • 21. [Letters from Washington. Food and Drug Administration and medical technology: at an impasse?].
    Gelijns AC
    Ned Tijdschr Geneeskd; 1993 Jan; 137(3):146-50. PubMed ID: 8423866
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 23. 2010 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2011 Feb; 10(2):82-5. PubMed ID: 21283092
    [No Abstract]   [Full Text] [Related]  

  • 24. Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758-9. PubMed ID: 10115699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engaging Patients Across the Spectrum of Medical Product Development: View From the US Food and Drug Administration.
    Hunter NL; O'Callaghan KM; Califf RM
    JAMA; 2015 Dec; 314(23):2499-500. PubMed ID: 26584067
    [No Abstract]   [Full Text] [Related]  

  • 26. The MedWatch Program.
    Love L; Couig MP
    J Toxicol Clin Toxicol; 1999; 37(6):803-7. PubMed ID: 10584596
    [No Abstract]   [Full Text] [Related]  

  • 27. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities.
    Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619
    [No Abstract]   [Full Text] [Related]  

  • 28. [Theoretical and practical aspects of statistic sampling and related norms of acceptance].
    Mattei A; Pietra E
    Boll Chim Farm; 1968 May; 107(5):287-95. PubMed ID: 5721540
    [No Abstract]   [Full Text] [Related]  

  • 29. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical devices of human origin.
    Williams D
    Med Device Technol; 2001 Apr; 12(3):8, 10-1. PubMed ID: 11547687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When names make claims: ethical issues in medical device marketing.
    Bramstedt KA
    Ethics Med; 2004; 20(2):47-57. PubMed ID: 15468483
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA & Y2K. Preparing for the new millennium.
    Lewis C
    FDA Consum; 1999; 33(6):6-11. PubMed ID: 10628310
    [No Abstract]   [Full Text] [Related]  

  • 33. MEDWATCH: the new FDA medical products reporting program.
    Kennedy DL
    Respir Care; 1993 Oct; 38(10):1077-80. PubMed ID: 10145891
    [No Abstract]   [Full Text] [Related]  

  • 34. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
    Rhea S
    Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431
    [No Abstract]   [Full Text] [Related]  

  • 35. Sterility requirement for aqueous-based drug products for oral inhalation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 May; 65(103):34082-9. PubMed ID: 11010719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs, devices, diagnostics, and policies: the year's review.
    Kupecz D
    Nurse Pract; 2000 Feb; 25(2):42, 45-8, 51-3; quiz 54-5. PubMed ID: 10703024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting to the FDA.
    Dippel JV
    RN; 1993 Dec; 56(12):61-2. PubMed ID: 8265993
    [No Abstract]   [Full Text] [Related]  

  • 38. Who would be affected if the FDA publishes mandatory standards? Or. . . Why Congress should get the FDA "off the hook".
    Miller MJ
    Med Instrum; 1986; 20(3):168. PubMed ID: 3724593
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA-medical device news corner.
    Salman NN
    J Biomed Mater Res; 1987 Dec; 21(A3 Suppl):251-7. PubMed ID: 3429465
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA moving on reuse regulation.
    OR Manager; 2000 Feb; 16(2):7. PubMed ID: 10787900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.